| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/15/2011 | US20110224276 optical isomer of phenylpropionic acid and its medicinal use |
| 09/15/2011 | US20110224275 Inhibitors of matrix metalloproteinases |
| 09/15/2011 | US20110224274 New Therapeutic Agents |
| 09/15/2011 | US20110224273 Pyrazole Derivatives as 11-Beta-HSD1 Inhibitors |
| 09/15/2011 | US20110224272 Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid |
| 09/15/2011 | US20110224271 process for the preparation of olmesartan medoxomil |
| 09/15/2011 | US20110224270 Synergistic microbicidal compositions |
| 09/15/2011 | US20110224269 Analgesic Compounds, Compositions, and Uses Thereof |
| 09/15/2011 | US20110224268 Compositions and methods of using R(+) pramipexole |
| 09/15/2011 | US20110224267 Selective androgen receptor modulators |
| 09/15/2011 | US20110224266 4 aminopyridine and a pharmaceutical composition for treatment of neuronal disorders |
| 09/15/2011 | US20110224265 Gel containing pirfenidone |
| 09/15/2011 | US20110224264 Medicaments |
| 09/15/2011 | US20110224263 Cyclic pyridyl-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 09/15/2011 | US20110224262 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 09/15/2011 | US20110224261 Crystalline form of 4-(5--4-methyl-4h-1,2,4-triazol-3-yl)pyridine |
| 09/15/2011 | US20110224260 Catechol-based derivatives for treating or preventing diabetics |
| 09/15/2011 | US20110224259 Novel inhibitors |
| 09/15/2011 | US20110224256 Therapeutic imprinting for the treatment of psychiatric disorders |
| 09/15/2011 | US20110224255 Tripeptidyl peptidase inhibitors |
| 09/15/2011 | US20110224254 Novel inhibitors |
| 09/15/2011 | US20110224253 Small-molecule inhibitors of the androgen receptor |
| 09/15/2011 | US20110224251 Therapeutic Pyrazolyl Thienopyridines |
| 09/15/2011 | US20110224250 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient |
| 09/15/2011 | US20110224249 Novel Hydrate Form |
| 09/15/2011 | US20110224248 Azaquinolones that inhibit prolyl hydroxylase |
| 09/15/2011 | US20110224247 Azaisoquinolinone derivatives as nk3 antagonists |
| 09/15/2011 | US20110224246 Pharmaceutical compositions comprising ascomycin |
| 09/15/2011 | US20110224245 Treatment Of Neurological Disorders Using Huperzine |
| 09/15/2011 | US20110224244 Adamantyl Benzamide Derivatives |
| 09/15/2011 | US20110224243 FZD2 Molulators in the Treatment of Alopecia |
| 09/15/2011 | US20110224242 Styrlyquinolines, their process of preparation and their therapeutic uses |
| 09/15/2011 | US20110224241 Isothiazole and pyrazole derivatives as fungicides |
| 09/15/2011 | US20110224240 Methods of treating cancer and related diseases |
| 09/15/2011 | US20110224239 Combinations Comprising a S1P Receptor Agonist and a JAK3 Kinase Inhibitor |
| 09/15/2011 | US20110224238 6, 9-Disubstituted Purine Derivatives and Their Use for Treating Skin |
| 09/15/2011 | US20110224237 Use of allopurinol for the treatment of palmar plantar erythrodysesthesia |
| 09/15/2011 | US20110224236 Treatment for pulmonary hypertension |
| 09/15/2011 | US20110224235 Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors |
| 09/15/2011 | US20110224234 Polymorph B of N--N-methyl-acetamide |
| 09/15/2011 | US20110224233 Stem cell cultures |
| 09/15/2011 | US20110224232 Treatment of Pulmonary Fungal Infection With Voriconazole via Inhalation |
| 09/15/2011 | US20110224231 Novel Lactams as Beta Secretase Inhibitors |
| 09/15/2011 | US20110224230 Bicyclic dihydroimidazolone cgrp receptor antagonists |
| 09/15/2011 | US20110224229 Novel Crystalline Form |
| 09/15/2011 | US20110224228 Antifungal agents |
| 09/15/2011 | US20110224227 Hematopoietic protection against chemotherapeutic compounds using selective cyclin-dependent kinase 4/6 inhibitors |
| 09/15/2011 | US20110224226 Compositions and methods for increasing blood platelet levels in humans |
| 09/15/2011 | US20110224225 Inhibitors of protein kinases |
| 09/15/2011 | US20110224224 Method of Optimizing the Treatment of Philadelphia-Positive Leukemia with Imatinib Mesylate |
| 09/15/2011 | US20110224223 MTOR Modulators and Uses Thereof |
| 09/15/2011 | US20110224222 Cdk inhibitor for the treatment of mesothelioma |
| 09/15/2011 | US20110224221 Hematopoietic protection against ionizing radiation using selective cyclin-dependent kinase 4/6 inhibitors |
| 09/15/2011 | US20110224220 Substituted tricyclic derivatives |
| 09/15/2011 | US20110224219 Melanocortin receptor agonists |
| 09/15/2011 | US20110224218 Method for inhibiting growth of cancer cells and cell telomere and diseases of cell proliferation by using heteroannelated anthraquinone derivative compounds |
| 09/15/2011 | US20110224217 Methods of treatment using heteroaryl compounds and compositions thereof |
| 09/15/2011 | US20110224216 Methods of Treating or Preventing Acute Erythema |
| 09/15/2011 | US20110224215 Pre-surgical treatment |
| 09/15/2011 | US20110224214 Process for preparing polymorph |
| 09/15/2011 | US20110224213 Use of Glutaric Acid Derivatives or the Pharmaceutically Acceptable Salts Thereof as Anti-Arrhythmic Agents |
| 09/15/2011 | US20110224212 Kinase inhibitor compounds |
| 09/15/2011 | US20110224211 Anti-Viral Compounds, Compositions, And Methods Of Use |
| 09/15/2011 | US20110224210 Novel bis-amides as anti-malarial agents |
| 09/15/2011 | US20110224209 4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl peptidase-1 (dpp-1) |
| 09/15/2011 | US20110224208 Novel inhibitors of flavivirus replication |
| 09/15/2011 | US20110224207 Flavivirus inhibitors and methods for their use |
| 09/15/2011 | US20110224206 Triazole compounds that modulate hsp90 activity |
| 09/15/2011 | US20110224205 Use of curcumin or its analogues in cancer therapy utilizing epidermal growth factor receptor tyrosine kinase inhibitor |
| 09/15/2011 | US20110224204 Di-substituted phenyl compounds |
| 09/15/2011 | US20110224203 Benzimidazole derivatives and their use as protein kinase inhibitors |
| 09/15/2011 | US20110224202 Pde10 inhibitors and related compositions and methods |
| 09/15/2011 | US20110224201 Cgrp receptor antagonists |
| 09/15/2011 | US20110224200 Therapeutic agent for chorioretinal degenerative disease containing pyridine-3-carbaldehyde 0-(piperidin-1-yl-propyl)-oxime derivative as active ingredient |
| 09/15/2011 | US20110224199 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues |
| 09/15/2011 | US20110224198 Aryl methyl benzoquinazolinine m1 receptor positive allosteric modulators |
| 09/15/2011 | US20110224197 Pyrimidines and pyridines useful as inhibitors of protein kinases |
| 09/15/2011 | US20110224196 Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent |
| 09/15/2011 | US20110224195 Heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 09/15/2011 | US20110224194 Staurosporine Derivatives as Inhibitors of FLT3 Receptor Tyrosine Kinase Activity |
| 09/15/2011 | US20110224193 Inhibitors of diacylglycerol acyltransferase |
| 09/15/2011 | US20110224192 3-Arylamino Pyridine Derivatives |
| 09/15/2011 | US20110224191 Substituted Pyrrolo[2,3-b]-Pyridines and -Pyrazines |
| 09/15/2011 | US20110224190 Piperidin-4-yl azetidine derivatives as jak1 inhibitors |
| 09/15/2011 | US20110224189 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 09/15/2011 | US20110224188 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-alpha]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES |
| 09/15/2011 | US20110224187 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof |
| 09/15/2011 | US20110224186 Carbacephem beta-lactam antibiotics |
| 09/15/2011 | US20110224185 Compounds and compositions as modulators of gpr119 activity |
| 09/15/2011 | US20110224184 Naphthoquinone derivatives useful for prevention of amyloid deposits and treatment of diseases involving amyloidogenesis |
| 09/15/2011 | US20110224183 16, 17-carbocyclic condensed steroid compounds having slective estrogenic activity |
| 09/15/2011 | US20110224182 Salts of (3-0-(3',3'-dimethylsuccinyl) betulinic acid and solid state forms thereof |
| 09/15/2011 | US20110224181 Methods for the treatment of a traumatic central nervous system injury |
| 09/15/2011 | US20110224180 Novel cholest-4-en-3-one oxime derivatives, pharmaceutical compositions containing same, and preparation method |
| 09/15/2011 | US20110224179 Medicament and method of diagnosis |
| 09/15/2011 | US20110224178 Composition and method for treating erectile dysfunction |
| 09/15/2011 | US20110224177 Combinations comprising antimuscarinic agents and corticosteroids |
| 09/15/2011 | US20110224176 Lyophilized Cake Formulations |
| 09/15/2011 | US20110224175 Formulations of canfosfamide and their preparation |
| 09/15/2011 | US20110224174 Creatine ester anti-inflammatory compounds and formulations |